In both the fasting patients and the normal volunteers, oral folic acid significantly increased the jejunal glycolytic enzyme activities but had no effect on disaccharidase activity. When oral folic acid was discontinued in the normal volunteers, the glycolytic enzyme activities returned to control values. In the obese patients, refeeding and folic acid caused a further increase in glycolytic enzyme activities above that seen with fasting and folic acid.
In contrast to oral folic acid, intramuscular folic acid, oral vitamin B12, and oral tetracycline had no effect on glycolytic enzyme activities.
These studies demonstrate that oral folic acid which is neither a substrate nor a coenzyme of these enzymes, increases human jejunal glycolytic enzyme activity in a specific fashion. This would appear to be an action of oral folic acid which has not been recognized previously.
INTRODUCTION
Human jejunal disaccharidase and glycolytic enzyme activities are regulated by dietary sugars (1, 2) . Spe tase activity is unchanged. In addition, high glucose diets increase jejunal glucokinase and hexokinase activities while high fructose diets increase fructokinase and fructose-i-phosphate aldolase activities. During the study of one patient with tropical sprue, it was found that his jejunal glycolytic enzymes responded poorly to diet. In view of the well-established effect of folic acid in the treatment of tropical sprue, it seemed appropriate to investigate the effect of folic acid on these enzymes in health and disease. In the present study, we report the effect of oral folic acid on the jejunal glycolytic enzyme activities of normal subjects and fasting obese patients. Also, the effect of tetracycline was studied because of its presently accepted use as an adjunct to folic acid therapy in tropical sprue. A preliminary report of part of this material has appeared (3).
METHODS
Subjects. Three normal male Caucasian volunteers,1 ranging in age from 19 to 25 yr, and five obese patients, one Negro and four Caucasians, ranging in age from 31 to 38 yr, were studied. All studies were conducted on a metabolic ward. Subjects were weighed daily after voiding and before breakfast. The obese patients were studied, before and after fasting and also after that refeeding which followed starvation, for weight reduction. Informed consent was obtained in all instances. Diets. A constant, part solid, part liquid diet was given to the normal subjects and to the obese patients during refeeding. The diet consisted of 3000 cal: 50% as carbohydrate, 30% as fat, and 20% as protein. The FIGURE 2 Mean glycolytic enzyme activities in three normal subjects after 7 days of diet alone, 7 days of diet plus folic acid, and 7 days of diet alone (study II). The SEM is in brackets. F-1,6-P,, fructose-1, 6-diphosphate;
F-1-P, fructose-i-phosphate. present in animal intestine (5, 6) . Whether this high Km hexokinase in human intestine is the same enzyme as type IV hexokinase of liver is not known. Until the isoenzyme pattern of hexokinases in human intestine is determined, our designation of the high Km hexokinase as glucokinase is considered tentative. In addition to the measurement of disaccharidase activity, the sucrase to lactase (S: L) and the maltase to lactase ratios (M: L) were also computed (1).
Regulation of Jejunal Glycolytic Enzymes by Oral Folic Acid
The addition of doses of folate ranging from 10 jug to 1000 jug directly to the assay system had no effect on the enzyme activities.
Studies. The investigations were divided into four studies. In study I, the five obese patients were fasted for 2 wk and then refed for 3 days. Folic acid, 5 mg by mouth, three times a day, was given during the 2nd wk of fasting and the 3 days of refeeding. Biopsies were performed on days 1, 4, 7, 8, 11, 14, 15, and 17. Two patients were biopsied on days 6 and 13 instead of 4 and 11.
In study II, the three normal subjects ate a constant 3000 cal diet (50% carbohydrate) for In study III, two obese patients were fasted for 2 wk and one normal subj ect was fed a constant diet for 3 wk. For all three, folic acid, 5 mg, three times a day, was given intramuscularly during the 2nd wk only. Biopsies were performed on days 1, 4, 7, 8, 11, and 14 for all three subjects and, also, on days 15, 18, and 21 in the normal subject.
In study IV, one obese patient was fasted for 2 wk and then fed a 1200 cal (50% carbohydrate) diet for 3 days. During the 2nd wk only, vitamin Bu, 500 jAg/day, was administered orally in three divided doses. Biopsies were performed on days 1, 4, 7, 8, 11, 14, 15, and 17.
Throughout most of the studies serum folate levels were measured before, during, and after folate administration. Serum folate levels were determined by the procedure of Herbert (7) with Lactobacillus casei as the test organism using Difco folic acid media (Difco Laboratories, Detroit, Mich.).
RESULTS
Oral folic acid treatment produced similar results in both the fasting patients and the normal subjects. The effect of oral folate administration on jejunal glycolytic enzyme activities in studies I and II is presented in Figs. 1 and 2 . Table I presents all the individual fructokinase values in studies I and II. Completely analogous data were obtained for the other four enzymes.2 There was a significant rise in the activities of all enzymes when oral folic acid was added to the regimen. In the obese patients, there was a further significant rise when diet was added. In the normal subjects, all enzyme activity returned to control values when the folate was discontinued.
The time response to oral folate and the effect of oral tetracycline administration on jejunal hexokinase activity in study II are presented in Fig. 3 . The rise in enzyme activity when folate was added to the regimen was complete in 1 day as was the fall back to control values when it was discontinued. Tetracycline had no discernible effect. Identical results were obtained for the other four enzymes. In study I the effect of oral folate 2 Complete data for all five enzymes will be supplied with The effect of diet, diet plus folic acid, and diet plus tetracycline on hexokinase activity in three normal subjects (study II).
and diet was complete in 1 day also (Fig. 4) . The subject who received no multivitamins had identical results as those who received them.
Effect of intramuscular folate and oral vitamin B1*.
In studies III and IV, intramuscular folate and oral vitamin B12 had no effect on glucokinase activity in one fasting obese patient (Fig. 5) . There was no effect on the other enzymes. Similar results, not shown here, were obtained in the other obese patient and the normal subject on a constant diet. Effect of folate on disaccharidases. Oral and intramuscular folate, vitamin B12, and tetracycline all failed to alter disaccharidase activity and the S: L and M: L ratios in any of the obese patients and normal subjects (Fig. 6 ).
Effect of serum folate. The level of jejunal glycolytic enzyme activity appears to be independent of the serum folate levels. In all instances, serum folate levels rose markedly with the institution of oral folate and remained high even though oral folate was discontinued. However, jejunal glycolytic enzyme activity fell abruptly 1 day after oral folate was discontinued (Fig.   7 ). The serum folate rose markedly after intramuscular administration without any change in jejunal enzyme activity.
DISCUSSION
These studies demonstrate that oral folic acid is capable of increasing significantly glycolytic enzyme activity in the human jejunum. This is true when folic acid is administered orally both to fasting obese patients and normal subjects on a constant diet. In contrast, intramuscular folic acid, oral tetracycline, and oral vitamin B12 have no effect on these enzymes. These results, which could not have been predicted from our present knowledge of folic acid and jejunal enzyme metabolism, suggest that folic acid plays a fundamental role in the regulation of jejunal glycolytic enzyme activity in man. This role of folate has not been recognized previously.
These investigations were a direct outgrowth of our earlier studies demonstrating that dietary sugars can regulate jejunal disaccharidase and glycolytic enzyme activity (1, 2 The fact that folic acid increases glycolytic enzyme activity but not disaccharidase activity lends further support to the postulate that there are at least two types of adaptive responses in the human jejunum (8, 9) . The regulation of glycolytic enzyme activity by dietary sugars is complete in 1 day or less and appears to be mediated through the villus epithelial cell directly (8, 9) . On the other hand, the regulation of disaccharidase activity by dietary sugars takes 2-5 days and appears to be mediated through the crypt cell and subsequent epithelial cell turnover (10) . It is suggested that one response is characteristic of brush border enzymes (disaccharidases) and the other characteristic of cytoplasmic enzymes (glycolytic enzymes). This concept of two different adaptive responses in the human jejunum is strengthened by the fact that folic acid does not alter disaccharidase activity (even after 7 days) but does increase glycolytic enzyme activity in 1 (1, 2) showing substrate and/or end productinduced increases in enzyme activity. Folic acid is not obviously metabolically related to the enzymes that it increases and, in addition, its effect is quite general. Therefore, to explain its action, it is necessary to invoke another mechanism other than substrate-induced increases in activity.
Folic acid is metabolized to a number of cofactors which are involved in a variety of reactions including the interconversion of serine and glycine, the donation of methyl groups to form methionine and thymidine, the formation of purines, and the formylation of methionyltRNA (11, 12) . In light of these pathways, the action of folic acid might be mediated through the formation of guanosine triphosphate (GTP) or through N-formylmethionyl-tRNA. In microorganisms, GTP is an important initiation factor for protein synthesis and polypeptide chain elongation and N-formylmethionyl-tRNA is necessary for the initiation of protein synthesis (12, 13) . There are some data to support the involvement of N-formylmethionyl-tRNA in mammalian systems, though this has not been conclusively proven (14, 15) . Our working hypothesis is that folic acid is metabolized to N'0-formyltetrahydrofolic acid which formylates methionyl-tRNA to produce N-formylmethionyl-tRNA. This is discussed in detail elsewhere (12, 16) . There may be, of course, other mechanisms whereby folic acid increases glycolytic enzyme activity, but at the moment, these mechanisms are not readily apparent.
The folate effect does not apply to all types of enzyme systems. For example, disaccharidases, which are membrane-bound enzymes, are not affected. This failure of folic acid to alter disaccharidase activity would rule out an increase in the rate of cell division in the crypts as an explanation for the folate effect. Since the effect of folate is demonstrable within 30 min (17) , this implies that the effect of folic acid is directly on the jejunal epithelial cell.
The metabolic significance of folate-mediated increases in jejunal glycolytic enzyme activity is not established. That the folate effect may have physiologic importance is suggested by the fact that doses as low as 100 lg, which is lower than the average daily dietary intake, are effective in increasing glycolytic enzyme activity (17) . If it could be shown that an interruption of folate metabolism interferred with the folate regulation of glycolytic activity, this would support further the concept that folate has a physiologic function in regulating glycolytic enzyme activity.
Recently, we have studied a patient with adult formiminotransferase (FIT) deficiency (18) . This patient was malnourished, underweight, had diarrhea, intermittent muscle spasms, and a normal jejunal biopsy. 24 hr urinary formiminoglutamic acid (FIGLU) was markedly elevated, serum folate was elevated, and she had subtle megaloblastic changes in her bone marrow. Large quantities of dietary sugars evoked typical symptoms. The activities of her jejunal glycolytic enzymes were low and there was little or no adaptive response of these enzymes to dietary sugars and oral folic acid.
The fact that this patient's jejunal glycolytic enzyme activity was low and responded poorly, if at all, to dietary sugars and oral folic acid suggests that folate metabolism must take place beyond the FIT step, possibly to N'0-formyltetrahydrofolate, in order for the folate effect to occur. These results are consistent with, but do not prove, the hypothesis that folic acid acts to increase certain types of protein synthesis.
In other preliminary studies in patients with tropical sprue (19) , it has been shown that jejunal glycolytic enzyme activity is very low and the adaptive response to dietary sugars is markedly impaired. Glycolytic enzyme activity and the adaptive response returns to normal with folate therapy.
We believe, therefore, that the regulation of jejunal glycolytic enzyme activity by oral folic acid is metabolically important and that interference with this regulation leads to clinically significant disease.
One might predict, then, that other patients will be discovered who have gastrointestinal symptoms related to a failure of adaptation of jejunal glycolytc enzymes to dietary sugars and/or folic acid.
